TY  - GEN
AU  - Pui,Ching-Hon
AU  - Pei,Deqing
AU  - Coustan-Smith,Elaine
AU  - Jeha,Sima
AU  - Cheng,Cheng
AU  - Bowman,W Paul
AU  - Sandlund,John T
AU  - Ribeiro,Raul C
AU  - Rubnitz,Jeffrey E
AU  - Inaba,Hiroto
AU  - Bhojwani,Deepa
AU  - Gruber,Tanja A
AU  - Leung,Wing H
AU  - Downing,James R
AU  - Evans,William E
AU  - Relling,Mary V
AU  - Campana,Dario
TI  - Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study
SN  - 1474-5488
PY  - 2015///0629
KW  - Adolescent
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Asparaginase
KW  - Child
KW  - Child, Preschool
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Infant
KW  - Male
KW  - Methotrexate
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Neoplasm, Residual
KW  - chemically induced
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Prednisone
KW  - Prospective Studies
KW  - Remission Induction
KW  - Risk Factors
KW  - United States
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(15)70082-3
ER  -